Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:

16 Years to 99 Years (Child, Adult, Senior)

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

No

Sampling Method:

Non-Probability Sample

Study Population

All patients who receive Humira for the treatment of Ankylosing Spondylitis

Criteria

Inclusion Criteria:

All patients with Ankylosing Spondylitis who are not responding well to conventional therapy and receive Humira will be enrolled in the survey

Exclusion Criteria:

Contraindications according to the Package Insert

Patients who have serious infections

Patients who have tuberculosis

Patients with a history of hypersensitivity to any ingredient of Humira

Patients who have demyelinating disease or with a history of demyelinating disease